Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approachesVivek Asati, Ghanshyam Das Gupta, Arjun Anant et al.|European Journal of Medicinal Chemistry|2021Cited by 72
Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date)Preeti Patel, Harish Rajak, Ruchi Shakya et al.|Journal of Molecular Structure|2023Cited by 60
Recent updates on structural insights of MAO-B inhibitors: a review on target-based approachGurkaran Singh Baweja, Vivek Asati, Bhupinder Kumar et al.|Molecular Diversity|2023Cited by 40
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as AnticancerAgentPreeti Patel, Vivek Asati, S. Vishakha et al.|Current Cancer Drug Targets|2022Cited by 40
An insight on medicinal attributes of 1,2,3‐ and 1,2,4‐triazole derivatives as alpha-amylase and alpha-glucosidase inhibitorsAnushka Sharma, Vivek Asati, Rahul Dubey et al.|Molecular Diversity|2023Cited by 24